Parkinson's disease: in vivo metabolic changes in the frontal and parietal cortices in 6-OHDA treated rats during different periods

Int J Neurosci. 2014 Feb;124(2):125-32. doi: 10.3109/00207454.2013.825616. Epub 2013 Aug 15.

Abstract

This study aims to investigate metabolic changes in frontal and parietal cortices in the 6-OHDA induced Parkinson's rats. Ratios of N-acetyl-aspartic acid/creatine (NAA/Cr), choline/creatine (Cho/Cr), and glumatic acid and glutamine glutaminic acid/creatine (Glx/Cr) of regions of interests (ROIs) in the frontal and parietal cortices, and the substantia nigra were analyzed. NAA/Cr, Cho/Cr and Glx/Cr in the frontal and parietal cortices in the lesion side did not show any significant differences two weeks after operation compared with the contralateral side (p > 0.05). NAA/Cr in the frontal cortex in the lesion side was significantly lower in the five weeks after operation; Cho/Cr remained normal; Glx/Cr increased (p < 0.05), and all ratios of parietal cortex were normal. In the eight weeks after operation, NAA/Cr in the frontal cortex in the lesion side was lower than that of the five weeks (p < 0.01), Cho/Cr still remained normal while Glx/Cr was higher than before (p < 0.01). Regarding the parietal cortex, NAA/Cr increased significantly, while Cho/Cr and Glx/Cr remained normal. In the 12 weeks after operation, NAA/Cr, Cho/Cr and Glx/Cr in frontal cortex were consistent with that of the eight weeks, while they remained at the normal level in parietal cortex. The NAA/Cr in the substantia nigra decreased and Cho/Cr increased significantly during 2-8 weeks, and remained at the same level during 8-12 weeks. There are metabolic disturbances in PD rats. The transient hyperfunction in the parietal cortex can be considered as a compensation for the dysfunction of the frontal cortex and substantia nigra.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aspartic Acid / analogs & derivatives
  • Aspartic Acid / metabolism
  • Choline / metabolism
  • Corpus Striatum / drug effects
  • Creatine / metabolism
  • Disease Models, Animal
  • Frontal Lobe / metabolism*
  • Functional Laterality
  • Functional Neuroimaging
  • Glutamates / metabolism
  • Glutamic Acid / metabolism
  • Glutamine / metabolism
  • Magnetic Resonance Spectroscopy
  • Male
  • Motor Activity / drug effects
  • Oxidopamine / toxicity*
  • Parietal Lobe / metabolism*
  • Parkinson Disease, Secondary / chemically induced
  • Parkinson Disease, Secondary / metabolism*
  • Rats
  • Substantia Nigra / metabolism
  • Time Factors

Substances

  • Glutamates
  • Glutamine
  • Aspartic Acid
  • Glutamic Acid
  • Oxidopamine
  • N-acetylaspartate
  • Creatine
  • Choline